Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the clinical benefit of two different dosing
schedules of zoledronic acid in patients with metastatic bone lesions from breast cancer who
have already been treated with zoledronic acid for about one year.